Please login to the form below

Not currently logged in
Email:
Password:

Haymarket Media acquires digital agency

Gains Group DCA from contract sales giant PDI

haymarket_300_200Haymarket Media has acquired digital communications agency Group DCA, expanding its coverage with healthcare providers.

Group DCA will operate as an independent entity within PRI Healthcare Solutions (PRI HCS), the custom medical communications division of Haymarket Media.

Lee Maniscalco, CEO of Haymarket Media, commented: “Adding Group DCA to our already robust digital offerings will position us strategically for continued leadership in healthcare communication.

“Group DCA's products naturally complement our own digital products and services and our cultures of high-energy creativity and innovation are highly compatible and mutually reinforcing. It is a perfect strategic and cultural fit, one that will help to accelerate our growth.”

The assets acquired through the transaction include Group DCA's proprietary DIAGRAM - DIAlog, GRAphics and Motion - platform and The Medical Bag, a website honed for health care professional salongside staff to support the business. The website will continue to run as an independent platform that also supports e-detailing programs.

Ron Scalici, the first Group DCA employee to join the organisation in 1999 and most recently chief innovations officer at PRI, will oversee Group DCA's every day operations as general manager.

Scalici added: “Joining Haymarket is an exciting opportunity for Group DCA. Integrating our DIAGRAM eDetailing platform and the Medical Bag website with Haymarket's expansive reach to healthcare providers will benefit out existing clients as well as Haymarket's.”

Group DCA will retain its name and its operations and services will continue.

Article by
Kirstie Pickering

10th March 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics